501 related articles for article (PubMed ID: 31216670)
1. The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs.
Hromadnikova I; Dvorakova L; Kotlabova K; Krofta L
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216670
[TBL] [Abstract][Full Text] [Related]
2. First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR.
Hromadnikova I; Kotlabova K; Ivankova K; Krofta L
PLoS One; 2017; 12(2):e0171756. PubMed ID: 28182660
[TBL] [Abstract][Full Text] [Related]
3. Prediction of severe preeclampsia and intrauterine growth restriction based on serum placental exosome miR-520a-5p levels during the first-trimester.
Xu XR; Cheng L; Wang YP
Medicine (Baltimore); 2024 May; 103(20):e38188. PubMed ID: 38758859
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.
Hromadnikova I; Kotlabova K; Ondrackova M; Pirkova P; Kestlerova A; Novotna V; Hympanova L; Krofta L
DNA Cell Biol; 2015 Jun; 34(6):437-57. PubMed ID: 25825993
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction.
Hromadnikova I; Kotlabova K; Krofta L
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203467
[TBL] [Abstract][Full Text] [Related]
6. First trimester prediction models for small-for- gestational age and fetal growth restricted fetuses without the presence of preeclampsia.
Hromadnikova I; Kotlabova K; Krofta L
Mol Cell Probes; 2023 Dec; 72():101941. PubMed ID: 37951512
[TBL] [Abstract][Full Text] [Related]
7. First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.
Hromadnikova I; Kotlabova K; Hympanova L; Doucha J; Krofta L
PLoS One; 2014; 9(12):e113735. PubMed ID: 25502889
[TBL] [Abstract][Full Text] [Related]
8. Postpartum profiling of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications.
Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
Int J Cardiol; 2019 Sep; 291():158-167. PubMed ID: 31151766
[TBL] [Abstract][Full Text] [Related]
9. Profiling of cardiovascular and cerebrovascular disease associated microRNA expression in umbilical cord blood in gestational hypertension, preeclampsia and fetal growth restriction.
Hromadnikova I; Kotlabova K; Ivankova K; Vedmetskaya Y; Krofta L
Int J Cardiol; 2017 Dec; 249():402-409. PubMed ID: 29121743
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction.
Hromadnikova I; Kotlabova K; Hympanova L; Krofta L
PLoS One; 2015; 10(9):e0138383. PubMed ID: 26394310
[TBL] [Abstract][Full Text] [Related]
11. First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers.
Hromadnikova I; Kotlabova K; Krofta L
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327520
[TBL] [Abstract][Full Text] [Related]
12. Circulating C19MC microRNAs in preeclampsia, gestational hypertension, and fetal growth restriction.
Hromadnikova I; Kotlabova K; Ondrackova M; Kestlerova A; Novotna V; Hympanova L; Doucha J; Krofta L
Mediators Inflamm; 2013; 2013():186041. PubMed ID: 24347821
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of gestational trophoblastic disease/neoplasia via quantification of circulating nucleic acids of placental origin using C19MC microRNAs, hypermethylated RASSF1A, and SRY sequences.
Hromadnikova I; Kotlabova K; Krofta L; Hron F
Tumour Biol; 2017 Apr; 39(4):1010428317697548. PubMed ID: 28381180
[TBL] [Abstract][Full Text] [Related]
14. Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood.
Hromadnikova I; Kotlabova K; Hympanova L; Krofta L
Thromb Res; 2016 Jan; 137():126-140. PubMed ID: 26632513
[TBL] [Abstract][Full Text] [Related]
15. Placental Exosomes as Early Biomarker of Preeclampsia: Potential Role of Exosomal MicroRNAs Across Gestation.
Salomon C; Guanzon D; Scholz-Romero K; Longo S; Correa P; Illanes SE; Rice GE
J Clin Endocrinol Metab; 2017 Sep; 102(9):3182-3194. PubMed ID: 28531338
[TBL] [Abstract][Full Text] [Related]
16. Circulating chromosome 19 miRNA cluster microRNAs in pregnant women with severe pre-eclampsia.
Miura K; Higashijima A; Murakami Y; Tsukamoto O; Hasegawa Y; Abe S; Fuchi N; Miura S; Kaneuchi M; Masuzaki H
J Obstet Gynaecol Res; 2015 Oct; 41(10):1526-32. PubMed ID: 26224638
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications.
Hromadnikova I; Kotlabova K; Krofta L
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142536
[TBL] [Abstract][Full Text] [Related]
18. First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers.
Hromadnikova I; Kotlabova K; Krofta L
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409311
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of candidate circulating microRNAs in maternal blood leukocytes of the patients with preeclampsia and gestational diabetes mellitus.
Hocaoglu M; Demirer S; Senturk H; Turgut A; Komurcu-Bayrak E
Pregnancy Hypertens; 2019 Jul; 17():5-11. PubMed ID: 31487656
[TBL] [Abstract][Full Text] [Related]
20. Postnatal Expression Profile of microRNAs Associated with Cardiovascular and Cerebrovascular Diseases in Children at the Age of 3 to 11 Years in Relation to Previous Occurrence of Pregnancy-Related Complications.
Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L; Sirc J
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
